Eyenovia, Inc. (EYEN) Financials
EYEN Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 28.8 million | 19.8 million |
2023-09-30 | 34.9 million | 19.1 million |
2023-06-30 | 29.3 million | 18.8 million |
2023-03-31 | 29.3 million | 13.5 million |
EYEN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -6.5 million | 572225 |
2023-09-30 | -7.5 million | 612969 |
2023-06-30 | -5.9 million | 493632 |
2023-03-31 | -7.9 million | 819064 |
EYEN Net Income
No data available :(
EYEN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 14.8 million | - | 1.8 million |
2023-09-30 | 20.7 million | - | 1.9 million |
2023-06-30 | 17.5 million | 13.2 million | 2.0 million |
2023-03-31 | 18.5 million | 7.5 million | 1.6 million |
EYEN Shares Outstanding
EYEN Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 145231 | 3.8 million | 2.9 million | 496533 |
2023-09-30 | 1.7 million | 3.6 million | 2.9 million | 203733 |
2023-06-30 | 1.2 million | 2.8 million | 3.1 million | 201516 |
2023-03-31 | 920865 | 2.5 million | 2.9 million | 195620 |
EYEN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 2589 | 280113 |
2023-09-30 | 1198 | 1198 |
2023-06-30 | - | 271209 |
2023-03-31 | - | 197026 |
EYEN
Price: $0.63
52 week price:
Earnings Per Share: -0.66 USD
P/E Ratio: -2.70
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 305981
Market Capitalization: 25.1 million